It’s fall 2020 and the world’s waiting for the first results from the vaccine trials.But as the moment of truth nears, the pressure on the vaccine makers intensifies.And while AstraZeneca and Johnson & Johnson get hit with curveballs, Pfizer finds itself caught in the crossfire of the U.S. Presidential election.Listen to new episodes 1 week early and to all episodes ad free with Wondery+. Join Wondery+ for exclusives, binges, early access, and ad free listening. Available in the Wondery App https://wondery.app.link/businesswars.Support us by supporting our sponsors!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.